SDH

Huawei Launches Industry's First fgOTN-Compliant Optical Transmission Product, Creating Intelligent Foundation for Electric Power and Transportation Sectors

Retrieved on: 
Wednesday, February 28, 2024

This innovation establishes a robust and reliable communication network for the energy and transportation sectors.

Key Points: 
  • This innovation establishes a robust and reliable communication network for the energy and transportation sectors.
  • The significance of secure and reliable communication networks cannot be overstated in sectors vital to national economies and public welfare, such as energy and transportation.
  • Huawei's fgOTN-compliant optical transmission products feature:
    High security and reliability: TDM-based hard pipes ensure 100% physical isolation between services.
  • Flexible client-side bandwidth access ranging from 2 Mbit/s to 100 Gbit/s, coupled with hitless bandwidth adjustment, addresses the evolving requirements of smart terminals.

RapidAI Announces Late-Breaking Abstract Simultaneously Published in NEJM; Highlights Key Data Revealed at ISC 2024

Retrieved on: 
Monday, February 12, 2024

Data Summaries from Key Studies:

Key Points: 
  • Data Summaries from Key Studies:
    Subgroup Analyses from the TIMELESS Trial, by Gregory Albers, M.D., presented and simultaneously published in the NEJM.
  • Key imaging criteria: target mismatch ratio of ≥1.8, mismatch volume of ≥15 mL, and ischemic core volume
  • Data showed a median reduction of 30 minutes per patient from door-to-mechanical thrombectomy (MT) after the integration of RapidAI.
  • “In the world of AI, clinical validation is paramount to instill confidence in clinician decision-making,” said Karim Karti, CEO of RapidAI.

New Late Breaking Preliminary Data Demonstrate Balt’s Squid™ Liquid Embolic May Improve Outcomes in Patients with Chronic Subdural Hematomas

Retrieved on: 
Friday, February 9, 2024

The preliminary data demonstrates that rates of complications thus far are low and embolizing the MMA for the treatment of Chronic Subdural Hematoma (cSDH) potentially improves the success rates of both surgical and non-surgical treatments.

Key Points: 
  • The preliminary data demonstrates that rates of complications thus far are low and embolizing the MMA for the treatment of Chronic Subdural Hematoma (cSDH) potentially improves the success rates of both surgical and non-surgical treatments.
  • Standard management included surgical drainage of the subdural hemorrhage for qualified patients and best medical management for patients who did not require surgery.
  • STEM, which completed enrollment last year, is the first prospective IDE trial investigating embolization of the MMA for the treatment of chronic Sub-Dural Hematoma (cSDH).
  • A Veterans Affairs (VA) study of cSDH found a prevalence rate of 79.4 per 100,000 persons.

SDH Unveils App Development Cost Calculator for Tech Startups

Retrieved on: 
Friday, January 12, 2024

HAMBURG, Germany, Jan. 12, 2024 /PRNewswire-PRWeb/ -- Startups and established companies embarking on software development projects have grappled with the uncertainty of rough, often unreliable pre-estimations. According to various industry reports, poor budget management is a primary reason for project failure. Estimation helps startups and companies plan their financial resources more effectively, reducing the risk of budget overruns.

Key Points: 
  • SDH, a one-stop digital transformation and software development company, is proud to announce the unveiling of its online software development cost calculator.
  • This cutting-edge tool is poised to reshape the landscape of cost and time estimation for tech startups and companies, addressing the challenge of product development estimation.
  • Enter the SDH software development cost calculator, a free solution designed to empower startups and companies with precision, simplicity, and financial clarity.
  • The SDH app development cost calculator is a transformative leap forward for tech startups and companies seeking a brighter, more predictable future in software development.

RapidAI Receives FDA Clearance of AI Module for Detection of Hemispheric Subdural Hematomas

Retrieved on: 
Thursday, November 9, 2023

RapidAI , the global leader in developing Artificial Intelligence (AI) and technology workflow solutions to combat life-threatening neurovascular, trauma, cardiac and vascular conditions, today announced it has received FDA clearance for Rapid SDH, its AI-powered module for the detection and notification of suspected hemispheric acute and chronic subdural hematoma.

Key Points: 
  • RapidAI , the global leader in developing Artificial Intelligence (AI) and technology workflow solutions to combat life-threatening neurovascular, trauma, cardiac and vascular conditions, today announced it has received FDA clearance for Rapid SDH, its AI-powered module for the detection and notification of suspected hemispheric acute and chronic subdural hematoma.
  • Together with Rapid ICH and Rapid Hyperdensity , the three modules comprise RapidAI’s unique and industry-best hemorrhagic and trauma care AI solution, designed to help teams on the front lines of patient assessment streamline decision making and expedite patient care.
  • The need for the RapidAI solution is urgent, with SDH cases in US patients expected to increase by nearly 80% before 2040 and current estimated mortality rates at 40-60% – underscored by neurosurgical workforce shortages across the country.
  • Rapid SDH leverages AI and the intelligence gained from analyzing hundreds of patient scans to help neurocritical care teams identify suspected hemispheric subdural hemorrhage faster and with a higher degree of accuracy than traditional methods.

Exploring F5G Evolution, Huawei Launches Three Enterprise Optical Network Solutions

Retrieved on: 
Friday, September 22, 2023

Richard Jin, President of Huawei Optical Business Product Line, said in his keynote speech, "Amid increasing application of AI, the industry poses new requirements on sensing and connectivity.

Key Points: 
  • Richard Jin, President of Huawei Optical Business Product Line, said in his keynote speech, "Amid increasing application of AI, the industry poses new requirements on sensing and connectivity.
  • Industry intelligence requires a sensing network and an all-optical network.
  • On top of that, we have launched a series of innovative F5G products and solutions to empower AI-enabled industries."
  • In the future, Huawei will continue to innovate based on F5G evolution, develop leading products and solutions, and work with customers and partners to facilitate intelligent upgrade of various industries.

Cogent selects GTA’s GNC Data Center for Guam Point of Presence

Retrieved on: 
Tuesday, August 8, 2023

GTA, the leading telecommunications provider in Guam, has announced that the GTA GNC Data Center is now a strategic point of presence (PoP) for Cogent Communications, one of the world’s largest Internet Service Providers (ISPs).

Key Points: 
  • GTA, the leading telecommunications provider in Guam, has announced that the GTA GNC Data Center is now a strategic point of presence (PoP) for Cogent Communications, one of the world’s largest Internet Service Providers (ISPs).
  • We are excited about the opportunities this partnership presents.”
    “We are thrilled to welcome Cogent to GTA’s GNC Data Center,” said Roland Certeza, President, and CEO of GTA.
  • GTA operates a data center on Guam offering a secure, managed environment for customers who need an alternative site for business data storage.
  • The company also runs Guam’s first locally owned cable landing station and data center in Piti.

Ascentage Pharma's Novel Drug Olverembatinib Recommended for a Breakthrough Therapy Designation in China for the Treatment of SDH-Deficient GIST, the Second BTD for the Drug

Retrieved on: 
Wednesday, May 31, 2023

To date, olverembatinib has been granted two Priority Review Designations that underscored the drug's promising therapeutic utility.

Key Points: 
  • To date, olverembatinib has been granted two Priority Review Designations that underscored the drug's promising therapeutic utility.
  • Drugs that have been granted BTDs are prioritized by the CDE in communications and exchange, and in receiving guidance to advance the drug development progress.
  • Furthermore, BTD-designated drugs will be eligible for Priority Review status and conditional approvals upon submission of a New Drug Application (NDA).
  • Antitumor activity of olverembatinib (HQP1351) in patients (pts) with tyrosine kinase inhibitor (TKI)–resistant succinate dehydrogenase (SDH)–deficient gastrointestinal stromal tumor (GIST).

Ascentage Pharma Presents Updated Results from Multiple Clinical Studies at American Society of Clinical Oncology Annual Conference

Retrieved on: 
Friday, May 26, 2023

As of December 9, 2022, 130 patients were enrolled and treated with APG-2449 at doses ranging from 900 to1,500 mg.

Key Points: 
  • As of December 9, 2022, 130 patients were enrolled and treated with APG-2449 at doses ranging from 900 to1,500 mg.
  • Meanwhile, patients with higher pFAK expression in tumor tissues at baseline tended to achieve better clinical responses than those with lower pFAK expression after APG-2449 treatment.
  • Efficacy Results: The median duration of treatment in the 20 patients with SDH-deficient GIST was 7.8 (1.81-42.3) months.
  • Conclusions: Alrizomadlin combined with pembrolizumab is well tolerated and demonstrates clinical efficacy in patients with cutaneous melanoma that had progressed on PD-1/PD-L1 immunotherapy.

GL’s Comprehensive SONET/SDH Testing and Analysis Solution

Retrieved on: 
Thursday, March 2, 2023

“GL’s SonetExpert™ is a powerful network testing tool designed to analyze, monitor, and test SONET/SDH networks.

Key Points: 
  • “GL’s SonetExpert™ is a powerful network testing tool designed to analyze, monitor, and test SONET/SDH networks.
  • The software monitors the network in real-time and provides detailed analysis, reporting features of various types of SONET/SDH channels including STS-1, STS-3c, STS-12c, STS-48c, and STS-192c.
  • The tool offers scanning and detection of incoming SONET/SDH traffic, ATM/PoS features, which allow in-depth analysis of ATM/PoS networks.
  • It also supports test and measurement capabilities, such as Bit Error Rate Testing (BERT) to evaluate the performance of the network.